Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Wesley J. Talcott"'
Autor:
Joseph A. Miccio, Wesley J. Talcott, Timil Patel, Henry S. Park, Michael Cecchini, Ronald R. Salem, Sajid A. Khan, Stacey Stein, Jeremy S. Kortmansky, Jill Lacy, Amol Narang, Joseph Herman, Salma K. Jabbour, Christopher L. Hallemeier, Kimberly Johung, Krishan R. Jethwa
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 27, Iss , Pp 15-23 (2021)
Purpose: Margin-negative (R0) resection is the only potentially curative treatment for patients with pancreatic ductal adenocarcinoma (PDAC). Pre-operative multi-agent chemotherapy alone (MAC) or MAC followed by pre-operative radiotherapy (MAC + RT)
Externí odkaz:
https://doaj.org/article/6cbac6a58777403cbed48d1acbe64aa0
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics.
Autor:
Kimberly L. Johung, Joseph M. Herman, Michael Cecchini, Stacey Stein, Joseph A. Miccio, Jill Lacy, Jeremy S. Kortmansky, Christopher L. Hallemeier, Salma K. Jabbour, Sajid A. Khan, Krishan R. Jethwa, Ronald R. Salem, Henry S. Park, Amol Narang, Timil Patel, Wesley J. Talcott
Publikováno v:
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 27, Iss, Pp 15-23 (2021)
Clinical and Translational Radiation Oncology, Vol 27, Iss, Pp 15-23 (2021)
Highlights • Complete resection is a potentially curative treatment for pancreatic cancer. • This report studies neoadjuvant chemotherapy with or without radiation. • The addition of radiation was associated with improved complete resection rat
Autor:
Wesley J. Talcott, Kevin Chen, Gabrielle W. Peters, Kati K. Reddy, Sheri M. Weintraub, Sarah S. Mougalian, Kerin Adelson, Suzanne B. Evans
Publikováno v:
International journal of radiation oncology, biology, physics. 114(1)
The COVID-19 pandemic largely suspended in-person scientific meetings because of risk of disease spread. In the era of vaccination and social distancing practices, meetings have begun returning to in-person formats. We surveyed attendees and potentia
Autor:
Benjamin H. Kann, Martin T. King, Vikram Jairam, Michael S. Leapman, Wesley J. Talcott, Paul L. Nguyen, Skyler B. Johnson, Joseph A. Miccio, James B. Yu, Henry S. Park
Publikováno v:
Prostate Cancer and Prostatic Diseases. 24:414-422
BACKGROUND Comparative effectiveness research (CER) using national registries influences cancer clinical trial design, treatment guidelines, and patient management. However, the extent to which treatment selection bias (TSB) affects overall survival
Autor:
Suzanne B. Evans, Pehr E. Hartvigson, Jacqueline R. Kelly, Lauren Tressel, H. Lincoln, Todd Pawlicki, Roy H. Decker, Eric C. Ford, Wesley J. Talcott, Lynn D. Wilson
Publikováno v:
Practical Radiation Oncology. 10:312-320
Purpose Peer review during physician chart rounds is a major quality assurance and patient safety step in radiation oncology. However, the effectiveness of chart rounds in detecting problematic treatment plans is unknown. We performed a prospective b
Autor:
Wesley J. Talcott, Suzanne B. Evans
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics
Publikováno v:
International Journal of Radiation Oncology, Biology, Physics
PURPOSE/OBJECTIVE(S): Studies have suggested that prior radiation dose to normal lung tissue is associated with poor COVID-19 outcomes. However, radiation dose to the heart may be an equally important consideration, given the impact of COVID-19 on ca
Rates of invasive disease and outcomes in NSCLC patients with biopsy suggestive of carcinoma in situ
Autor:
Joseph A. Miccio, Benjamin H. Kann, Roy H. Decker, Jacob Sands, Lynette M. Sholl, Frank C. Detterbeck, Abby White, Lisa Singer, Wesley J. Talcott, Henry S. Park, David Kozono, Raymond H. Mak
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 157
Carcinoma in situ is a rare non-invasive histology of non-small cell lung cancer (NSCLC) with excellent survival outcomes with resection. However, management of lung biopsy suggestive of in situ disease remains unclear. To inform decision-making in t
Autor:
Joseph A, Miccio, Wesley J, Talcott, Vikram, Jairam, Henry S, Park, James B, Yu, Michael S, Leapman, Skyler B, Johnson, Martin T, King, Paul L, Nguyen, Benjamin H, Kann
Publikováno v:
Prostate cancer and prostatic diseases. 24(2)
Comparative effectiveness research (CER) using national registries influences cancer clinical trial design, treatment guidelines, and patient management. However, the extent to which treatment selection bias (TSB) affects overall survival (OS) in can